A bactericidal guanidinomethyl biaryl that alters the dynamics of bacterial FtsZ polymerization.

Malvika Kaul , Ajit K. Parhi , Yongzheng Zhang , Edmond J. LaVoie
Journal of Medicinal Chemistry 55 ( 22) 10160 -10176

38
2012
Detecting allosteric sites of HIV-1 reverse transcriptase by X-ray crystallographic fragment screening.

Joseph D. Bauman , Disha Patel , Chhaya Dharia , Marc W. Fromer
Journal of Medicinal Chemistry 56 ( 7) 2738 -2746

56
2013
Phenyl Substituted 4-Hydroxypyridazin-3(2H)-ones and 5-Hydroxypyrimidin-4(3H)-ones: Inhibitors of Influenza A Endonuclease

Hye Yeon Sagong , Joseph D. Bauman , Disha Patel , Kalyan Das
Journal of Medicinal Chemistry 57 ( 19) 8086 -8098

36
2014
Developing and Evaluating Inhibitors against the RNase H Active Site of HIV-1 Reverse Transcriptase.

Paul L. Boyer , Steven J. Smith , Xue Zhi Zhao , Kalyan Das
Journal of Virology 92 ( 13)

37
2018
Evolving understanding of HIV-1 reverse transcriptase structure, function, inhibition, and resistance.

Francesc Xavier RUIZ , Eddy Arnold
Current Opinion in Structural Biology 61 113 -123

32
2020
Taking aim at a moving target: designing drugs to inhibit drug-resistant HIV-1 reverse transcriptases.

Stefan G Sarafianos , Kalyan Das , Stephen H Hughes , Eddy Arnold
Current Opinion in Structural Biology 14 ( 6) 716 -730

120
2004
Structures of RNA polymerase-antibiotic complexes

Mary X Ho , Brian P Hudson , Kalyan Das , Eddy Arnold
Current Opinion in Structural Biology 19 ( 6) 715 -723

137
2009
Proteins: how RNA polymerases work.

Patrick Cramer , Eddy Arnold
Current Opinion in Structural Biology 19 ( 6) 680 -682

5
2009
Structure of a Dihydroxycoumarin Active-Site Inhibitor in Complex with the RNase H Domain of HIV-1 Reverse Transcriptase and Structure–Activity Analysis of Inhibitor Analogs

Daniel M. Himmel , Nataliya S. Myshakina , Tatiana Ilina , Alexander Van Ry
Journal of Molecular Biology 426 ( 14) 2617 -2631

38
2014
Extension into the entrance channel of HIV-1 reverse transcriptase—Crystallography and enhanced solubility

Mariela Bollini , Kathleen M. Frey , José A. Cisneros , Krasimir A. Spasov
Bioorganic & Medicinal Chemistry Letters 23 ( 18) 5209 -5212

34
2013
Why Do HIV-1 and HIV-2 Use Different Pathways to Develop AZT Resistance?

Paul L Boyer , Stefan G Sarafianos , Patrick K Clark , Eddy Arnold
PLOS Pathogens 2 ( 2) 101 -111

83
2006
Drug Resistance in Non-B Subtype HIV-1: Impact of HIV-1 Reverse Transcriptase Inhibitors

Kamalendra Singh , Jacqueline Flores , Karen Kirby , Ujjwal Neogi
Viruses 6 ( 9) 3535 -3562

22
2014
Alpha-carboxynucleoside phosphonates: direct-acting inhibitors of viral DNA polymerases

Jan Balzarini , Alan Ford , Nuala M Maguire , Jubi John
Future Medicinal Chemistry 11 ( 2) 137 -154

3
2019
Structural Basis for the Role of the K65R Mutation in HIV-1 Reverse Transcriptase Polymerization, Excision Antagonism, and Tenofovir Resistance

Kalyan Das , Rajiv P Bandwar , Kirsten L White , Joy Y Feng
Journal of Biological Chemistry 284 ( 50) 35092 -35100

76
2009
Design, synthesis, and SAR of a novel pyrazinone series with non-nucleoside HIV-1 reverse transcriptase inhibitory activity.

Jan Heeres , Marc R. de Jonge , Lucien M. H. Koymans , Frits F. D. Daeyaert
Journal of Medicinal Chemistry 48 ( 6) 1910 -1918

40
2005
Synthesis of novel diarylpyrimidine analogues and their antiviral activity against human immunodeficiency virus type 1.

Jerome Guillemont , Elisabeth Pasquier , Patrice Palandjian , Daniel Vernier
Journal of Medicinal Chemistry 48 ( 6) 2072 -2079

100
2005